30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Sunshine Biopharma Inc (SBFM)

Track

The most recent insider trading activity occurred on March 4, 2024, with the CEO, Steve N. Slilaty, purchasing 100,000 shares. Prior to this, on February 8, 2024, the CEO also bought 20,000 shares. Earlier transactions include purchases by the CFO/Secretary, Camille Sebaaly, in late 2022 and mid-2022.
Stock chart
Ticker: SBFM Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Slilaty Steve N.
Chief Executive Officer
1 purchase — total 10,000 USD
Buy 4 Mar 2024
Value US$1,960,667.52 | Price 41.17 | Shares 67,457
Buy 8 Feb 2024
Value US$2,003,530.10 | Price 181.84 | Shares 36,679
Buy 30 Nov 2022
Value US$22,905.00 | Price 0.76 | Shares 30,000
Buy 3 Jun 2022
Value US$30,500.00 | Price 1.22 | Shares 25,000
Buy 12 Apr 2016
Value US$50,009.00 | Price 0.20 | Shares 253,082
Buy 27 May 2015
Value US$50,000.00 | Price 0.10 | Shares 500,000
Sale 4 Sep 2012
Value US$129,575.00 | Price 0.05 | Shares 2,591,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-05 2024-03-04 B Purchase
Slilaty Steve N.

Chief Executive Officer

Executive Director Large shareholder
67,457 +43.6%
41.17
US$1,960,668 		67,457 +43.6% 41.17 US$1,960,668
2024-02-12 2024-02-08 B Purchase
Slilaty Steve N.

Chief Executive Officer

Executive Director Large shareholder
36,679 +12.3%
181.84
US$2,003,530 		36,679 +12.3% 181.84 US$2,003,530
2022-12-02 2022-11-30 B Purchase
1.6
Sebaaly Camille

CFO/Secretary

Officer
13,286 +13.3%
175.36
US$1,630,268 		13,286 +13.3% 175.36 US$1,630,268
2022-06-06 2022-06-03 B Purchase
1.6
Sebaaly Camille

CFO/Secretary

Officer
25,000 +20.9%
1.22
US$30,500 		25,000 +20.9% 1.22 US$30,500
2016-04-26 2016-04-12 B Purchase
Slilaty Steve N.

Chief Executive Officer

Executive Director
253,082 +0.8%
0.20
US$50,009 		253,082 +0.8% 0.20 US$50,009
2015-06-01 2015-05-27 B Purchase
Slilaty Steve N.

Chief Executive Officer

Executive Director Large shareholder
500,000 +inf%
0.10
US$50,000 		500,000 +inf% 0.10 US$50,000
2012-09-07 2012-09-04 S Sale
Slilaty Steve N.

Chief Executive Officer

Executive Director Large shareholder
2,591,500 -7.6%
0.05
US$129,575 		2,591,500 -7.6% 0.05 US$129,575
Explore more

More insider trading research around Sunshine Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America